aspartic acid has been researched along with etoposide in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Pawlicki, M; Zuchowska-Vogelgesang, B | 1 |
| Cavolina, P; Di Leonardo, A; Maddalena, A | 1 |
| Kataoka, S; Kawai, H; Mashima, T; Naito, M; Tsuruo, T | 1 |
| Cowan, KH; Gudas, JM; Li, T; Nguyen, H; Robey, R; Sadzewicz, L; Wosikowski, K | 1 |
| Bastow, KF; Goz, B | 1 |
| Fujita, N; Nagahashi, A; Nagashima, K; Rokudai, S; Tsuruo, T | 1 |
| Keogh, SA; Martin, SJ; Slee, EA | 1 |
| Arrigo, AP; Bruey, JM; Fromentin, A; Garrido, C; Hilpert, S; Paul, C; Solary, E | 1 |
| Chung, CW; Jo, DG; Jung, YK; Kim, BJ; Kim, IK; Kim, KW; Kwon, YK; Song, YH; Woo, HN | 1 |
| Koh, YH; Tanzi, RE; Tesco, G | 1 |
| Arseven, OK; Chen, F; Cryns, VL | 1 |
| Borst, J; de Vries, E; Eldering, E; Tait, SW; Werner, AB | 1 |
| Bennett, LN; Clarke, CA; Clarke, PR | 1 |
| Cardinale, S; Carvalho, A; Earnshaw, WC; Gassmann, R; Gudmundsdottir, E; Lai, F; Morrison, CG; Ogawa, H; Ribeiro, S; Ruchaud, S; Xu, Z; Yuan, X; Yue, Z | 1 |
| Chen, GQ; Duan, XF; Wen, DH; Zhao, M | 1 |
| Du, ZX; Gao, YY; Liu, BQ; Meng, X; Niu, XF; Wang, HQ; Zhang, HY | 1 |
| Hong, Y; Jang, SW; Ye, K | 1 |
| Anania, VG; Ashkenazi, A; Bakalarski, CE; Bustos, D; Forrest, WF; Jhunjhunwala, S; Kirkpatrick, DS; Lill, JR; Pham, VC; Phung, QT; Pitti, R; Yu, K | 1 |
1 review(s) available for aspartic acid and etoposide
| Article | Year |
|---|---|
[New antineoplastic agents, their value and use].
Topics: Aminacrine; Antineoplastic Agents; Aspartic Acid; Cisplatin; Etoposide; Humans; Ifosfamide; Interferons; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Neoplasms; Phosphonoacetic Acid; Razoxane; Tamoxifen; Teniposide; Vinca Alkaloids | 1982 |
18 other study(ies) available for aspartic acid and etoposide
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
DNA topoisomerase II inhibition and gene amplification in V79/B7 cells.
Topics: Animals; Aspartate Carbamoyltransferase; Aspartic Acid; Benzamides; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cells, Cultured; Chromosome Aberrations; Cricetinae; Cricetulus; Dihydroorotase; DNA Damage; DNA Repair; Drug Resistance; Etoposide; Gene Amplification; Multienzyme Complexes; Phosphonoacetic Acid; Topoisomerase II Inhibitors | 1993 |
Aspartate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells.
Topics: Antineoplastic Agents; Apoptosis; Aspartic Acid; Camptothecin; Caspase 1; Cell Cycle; Cell Line; Cysteine Endopeptidases; Cytarabine; DNA, Neoplasm; Doxorubicin; Etoposide; Humans; Kinetics; Leukemia, Myeloid; Time Factors; Tumor Cells, Cultured | 1995 |
Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein.
Topics: Amides; Antineoplastic Agents; Aspartic Acid; Blotting, Western; Breast Neoplasms; Cell Cycle; Clone Cells; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Female; Flow Cytometry; Gene Expression; Genes, p53; Humans; Immunohistochemistry; Melphalan; Mitoxantrone; Neoplasm Proteins; Nuclear Proteins; Phosphonoacetic Acid; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Pyrazoles; Ribonucleosides; Ribose; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1996 |
A possible role for topoisomerase II in cell death and N-phosphonoacetyl-L-aspartate-resistance frequency and its enhancement by 1-beta-D-arabinofuranosyl cytosine and 5-fluoro-2'-deoxyuridine.
Topics: Animals; Antimetabolites, Antineoplastic; Aspartic Acid; Cell Death; Cell Line; Cricetinae; Cytarabine; DNA; DNA Topoisomerases, Type II; Drug Resistance; Drug Synergism; Enzyme Induction; Etoposide; Floxuridine; Gene Amplification; Humans; Kidney; Phosphonoacetic Acid | 1997 |
Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
Topics: Animals; Apoptosis; Aspartic Acid; bcl-X Protein; Binding Sites; Caspase 3; Caspases; Coumarins; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Enzyme Activation; Etoposide; Gene Expression Regulation; Humans; Interleukin-2; Mice; Oligopeptides; Peptide Fragments; Protease Inhibitors; Proto-Oncogene Proteins c-bcl-2; T-Lymphocytes; Transfection | 1998 |
Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release.
Topics: Animals; Apoptosis; Aspartic Acid; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspase 3; Caspases; Catalysis; Cell-Free System; Cycloheximide; Cytochrome c Group; Enzyme Inhibitors; Etoposide; Humans; Jurkat Cells; Mice; Mitochondria, Liver; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Tumor Cells, Cultured; Ultraviolet Rays | 2000 |
Differential regulation of HSP27 oligomerization in tumor cells grown in vitro and in vivo.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Apoptosis; Aspartic Acid; Biopolymers; Caspase 3; Caspase 9; Caspases; Cell Communication; Cell Count; Cell-Free System; Cisplatin; Colorectal Neoplasms; Coumarins; Etoposide; Heat-Shock Proteins; Mice; Molecular Weight; Mutagenesis, Site-Directed; Neoplasm Proteins; Oligopeptides; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Rats; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured | 2000 |
Caspase cleavage product lacking amino-terminus of IkappaBalpha sensitizes resistant cells to TNF-alpha and TRAIL-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Aspartic Acid; beta-Galactosidase; Blotting, Western; Caspases; DNA Primers; DNA-Binding Proteins; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Female; Fibroblasts; Humans; I-kappa B Proteins; Luciferases; Membrane Glycoproteins; NF-kappa B; NF-KappaB Inhibitor alpha; Paclitaxel; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Caspase activation increases beta-amyloid generation independently of caspase cleavage of the beta-amyloid precursor protein (APP).
Topics: Amyloid beta-Peptides; Animals; Apoptosis; Aspartic Acid; Binding Sites; Blotting, Western; Caspase 3; Caspases; CHO Cells; Cricetinae; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Etoposide; In Situ Nick-End Labeling; Mutagenesis, Site-Directed; Nucleic Acid Synthesis Inhibitors; Protein Binding; Protein Structure, Tertiary; Staurosporine; Time Factors; Transfection | 2003 |
Proteolysis of the mismatch repair protein MLH1 by caspase-3 promotes DNA damage-induced apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Apoptosis Regulatory Proteins; Aspartic Acid; Base Pair Mismatch; Carrier Proteins; Caspase 3; Caspases; Cell Line, Tumor; Cell Nucleus; Cytoplasm; DNA Damage; DNA Repair; Etoposide; Female; Humans; Male; Membrane Glycoproteins; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; Recombinant Proteins; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2004 |
Requirement for aspartate-cleaved bid in apoptosis signaling by DNA-damaging anti-cancer regimens.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aspartic Acid; BH3 Interacting Domain Death Agonist Protein; Carrier Proteins; Caspase 2; Caspase 8; Caspase 9; Caspases; Cell Line; Cytochromes c; Cytoplasm; DNA Damage; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Etoposide; Flow Cytometry; Gamma Rays; Genes, Dominant; Granzymes; Humans; Immunoblotting; Jurkat Cells; Leukemia, T-Cell; Liver; Mice; Mitochondria; Models, Biological; Mutation; Retroviridae; RNA, Small Interfering; Serine Endopeptidases; Signal Transduction; Tumor Suppressor Protein p53; Up-Regulation | 2004 |
Cleavage of claspin by caspase-7 during apoptosis inhibits the Chk1 pathway.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Motifs; Amino Acid Sequence; Animals; Apoptosis; Aspartic Acid; Binding Sites; Caspase 7; Caspases; Cell Cycle; Cell Line; Cell Nucleus; Cell-Free System; Checkpoint Kinase 1; Cycloheximide; Cytosol; DNA; DNA Replication; Dose-Response Relationship, Drug; Drosophila; Etoposide; HeLa Cells; Humans; Immunoprecipitation; Jurkat Cells; Mice; Models, Biological; Molecular Sequence Data; Oligonucleotides; Phosphorylation; Protein Binding; Protein Kinases; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Recombinant Proteins; Sequence Homology, Amino Acid; Signal Transduction; Time Factors; Xenopus; Xenopus Proteins | 2005 |
Deconstructing Survivin: comprehensive genetic analysis of Survivin function by conditional knockout in a vertebrate cell line.
Topics: Amino Acid Motifs; Animals; Aspartic Acid; Aurora Kinases; Cell Death; Cell Line; Cell Separation; Cell Survival; Centromere; Chickens; Cyclin-Dependent Kinases; Cytokinesis; Etoposide; Microtubule-Associated Proteins; Mitochondrial Proteins; Mitosis; Mutation; Phenotype; Phosphorylation; Phosphothreonine; Protein Binding; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Spindle Apparatus; Staurosporine; Temperature; Vertebrates | 2008 |
PU.1, a novel caspase-3 substrate, partially contributes to chemotherapeutic agents-induced apoptosis in leukemic cells.
Topics: Antineoplastic Agents; Apoptosis; Aspartic Acid; Camptothecin; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Etoposide; Humans; Leukemia; Mutagenesis, Site-Directed; Oligopeptides; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Trans-Activators | 2009 |
Characterization of BAG3 cleavage during apoptosis of pancreatic cancer cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Apoptosis Regulatory Proteins; Aspartic Acid; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cysteine Proteinase Inhibitors; Etoposide; Humans; Leupeptins; Mutation; Pancreatic Neoplasms; Peptide Fragments; Protein Processing, Post-Translational; Protein Structure, Tertiary; Recombinant Proteins; Staurosporine; Time Factors; Transfection; Tumor Necrosis Factor-alpha; Ultraviolet Rays | 2010 |
The N-terminal fragment from caspase-cleaved serine/arginine protein-specific kinase2 (SRPK2) translocates into the nucleus and promotes apoptosis.
Topics: 14-3-3 Proteins; Active Transport, Cell Nucleus; Apoptosis; Aspartic Acid; Binding Sites; Caspases; Cell Nucleus; Down-Regulation; Etoposide; HEK293 Cells; Humans; Mutation; Peptide Fragments; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt | 2011 |
Complementary proteomic tools for the dissection of apoptotic proteolysis events.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Aspartic Acid; BH3 Interacting Domain Death Agonist Protein; Caspases; Computational Biology; Etoposide; HCT116 Cells; Humans; Jurkat Cells; Nuclear Proteins; Peptides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Proteins; Proteolysis; Proteomics; RNA-Binding Proteins; Sequestosome-1 Protein; Substrate Specificity; Transcription Factors | 2012 |